Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by bluebeard123on Jul 29, 2020 8:36am
145 Views
Post# 31335649

RE:RE:RE:RE:RE:Bring it on SEEKING ALPHA

RE:RE:RE:RE:RE:Bring it on SEEKING ALPHALots of wrong info in the SA article e.g. testing market worldwide is $4.3B ( it's way more than that), need for covid19 testing will go away once vaccine developed (totally wrong!), sona is in crowded testing market and will not be able to get good market share (wrong again - current tests are inadequate) , etc, etc, etc. The SA article does make a couple of valid points: Sona is very highly priced for a company with no revenues; the insiders have a long history of stock promotion (I've seen it myself. I've owned mining stocks promoted by them). In the next couple of days, we expect very good field studies. When significant pre-orders, this will take counter the main negative about the company i.e. no revenues.
Bullboard Posts